Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks. [electronic resource]
Producer: 20161213Description: 301-307 p. digitalISSN:- 1600-0641
- 2-Naphthylamine
- Adult
- Aged
- Anilides -- administration & dosage
- Antiviral Agents -- administration & dosage
- Carbamates -- administration & dosage
- Cyclopropanes
- Drug Administration Schedule
- Drug Combinations
- Drug Resistance, Viral
- Drug Therapy, Combination -- methods
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Humans
- Lactams, Macrocyclic
- Liver Cirrhosis -- complications
- Macrocyclic Compounds -- administration & dosage
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Ribavirin -- administration & dosage
- Ritonavir -- administration & dosage
- Sulfonamides -- administration & dosage
- Sustained Virologic Response
- Treatment Outcome
- Uracil -- administration & dosage
- Valine
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.